VNDA - Vanda Pharmaceu Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (0.82%) SPX (%) TVIX (%) ZS (3.1%) SPLK (1.38%) QQQ (0.89%) PNC (-0.16%) PG (0.26%) PFE (0.76%) PANW (2.05%) NVS (1.17%) MSFT (1.12%) MRK (1.48%) MCD (1.03%) IWM (0.83%) GOOGL (0.68%) GE (-2.63%) FB (-0.15%) ETHUSD (%) EKSO (0.09%) DIS (0.47%) CVX (1.51%) CMI (1.06%) CLUB (14.05%) BAC (0.79%)

VNDA - Vanda Pharmaceutical...

$15.06 -0.06[-0.4%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$15.12	Open	$15.16
Volume	682.2K	Market Cap	788.1M
Yield		Last Dividend

Day

52 Week

Biotech Stock Roundup: CELG's Inrebi...	8:00 AM
Key highlights of the past week include drug approvals, and other regulatory and pipeline news.

Vanda Pharmaceuticals Announces the Appo...	4:00 AM
WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (VNDA), a global biopharmaceutical company focused on the development and...

Vanda Receives CRL From FDA for sNDA of ...	08/20/19
Vanda Pharmaceuticals (VNDA) receives a CRL from the FDA for the sNDA of Hetlioz (tasimelteon) to treat Jet Lag Disorder.

FDA rejects Vanda’s drug application for...	08/19/19
“We are deeply disappointed to have not received approval at this time, given our previous discussions with the FDA on this program,” said Dr. Mihael ...

FDA Issues Complete Response For Vanda's...	08/19/19
Vanda said Monday ahead of the market open the FDA has issued a complete response letter for its sNDA for Hetlioz in treating jet lag disorder. Hetl...

Vanda Pharmaceuticals FDA Update for HET...	08/19/19
WASHINGTON, Aug. 19, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (VNDA) today announced that on August 16 2019, it received a Complete Res...

Biotech Stock On The Radar: Is Vanda A B...	08/13/19
Small-cap biopharma Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has withstood the market-wide sell-off witnessed in early August, thanks to the second-q...

The Week Ahead In Biotech: Vanda Awaits ...	08/11/19
Biotech stocks came under pressure this week along with the broader market amid an earnings spate. The biggest news break was an FDA probe into data i...

Edited Transcript of VNDA earnings confe...	08/09/19
Q2 2019 Vanda Pharmaceuticals Inc Earnings Call

Why Vanda (VNDA) Might be Well Poised fo...	08/08/19
Vanda (VNDA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Vanda Pharmaceuticals Returns to Profita...	08/05/19
The stock popped after the company reported a solid quarter of operations, but serious red flags remain.

ANALYST RATINGS

2 analyst ratings (Last 6 months)

50.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	08/01/19
Citi upgrades from Neutral to Buy rating and announces Price Target of $19.00

Hold rating	07/25/19
Stifel Nicolaus downgrades from Buy to Hold rating and lowers Price Target from $26.00 to $17.00

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $VNDA

Service Name	Trader	% Success
Swing for the fences	Gino Baldassano	78.00 %	Follow
Alpha Swing Trades	Jonathan	69.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.